Announced
Completed
Financials
Sources
Tags
Completed
Single Bidder
Acquisition
Pharmaceuticals
pharmaceutical
Cross Border
Majority
Private
United States
Friendly
Synopsis
Endo, a specialty pharmaceutical company, completed the acquisition of the six development-stage, ready-to-use injectable product candidates of Nevakar Injectables, a biopharmaceutical company, for $35m. "These six product candidates that would be used in critical care settings meaningfully expand Endo's ready-to-use injectable product pipeline. We look forward to further developing and bringing these durable and differentiated products to market—and to the healthcare providers and patients who need them," Scott Sims, Endo Senior Vice President and General Manager in Injectable Solutions & Generics.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.